SphingoTec: Jörg Menten

SphingoTec has appointed Jörg Menten its chief commercial officer. He spent 13 years at Boehringer Mannheim including in roles with the firm's point-of-care and lab diagnostics operations, and was CFO of the Boheringer Mannheim Group. He also was president international for Kinetic Concepts, a developer of medical technologies for wounds and wound healing. He later was CEO of Vanguard, a European hospital services firm, and he was president international of CeloNova, a developer of medical devices for treating cardiovascular diseases, prior to its acquisition by Boston Scientific in 2015.